Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Business man marking buy on board and underlining it.

Image Source: Getty Images

News Corporation (ASX: NWS)

According to a note out of Goldman Sachs, its analysts have retained their buy rating and increased their price target on this media giant's shares to $45.20. This follows the release of News Corp's first quarter update, which the broker described as "high quality". Goldman also notes that management's outlook for the remainder of FY 2022 was positive. This gives the broker confidence that the company will achieve its full year EBITDA estimate of US$1.6 billion, which represents 21% year on year growth. The News Corp share price is trading at $33.01 today.

REA Group Limited (ASX: REA)

A note out of Macquarie reveals that its analysts have retained their outperform rating and lifted their price target on this property listings company's shares to $192. The broker made the move following the release of a strong first quarter update from REA Group. Its analysts were pleased with the company's performance and particularly the strong ad yield growth. The REA Group share price is fetching $170.03 on Monday.

Sonic Healthcare Limited (ASX: SHL)

Analysts at Morgan Stanley have retained their overweight rating and lifted their price target on this healthcare company's shares to $46.10. According to the note, the broker has upgraded its earnings estimates to reflect robust COVID-19 testing volumes. Morgan Stanley notes that global testing data reveals that demand remains strong and it expects Sonic to be benefiting greatly. The Sonic share price is trading at $39.76 on Monday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended REA Group Limited and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A little girl has a huge smile and a giant lollipop.
Broker Notes

6 ASX shares tipped by brokers to rise 34% to 87%

Post-earnings season, brokers have updated their 12-month price targets on scores of stocks.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

2 ASX shares tipped to return 19% to 47%

Recent sell-offs have caught Morgans’ attention, with the broker now rating both shares as buys.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Buy, hold, sell: Dicker Data, Polynovo, Flight Centre shares

Here's what the experts think.

Read more »

Two scientists analysing results on a computer screen.
Healthcare Shares

3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

After slumping to a 9-year low on 3 June, healthcare shares have rallied by an extraordinary 42%.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

How high could Bubs Australia shares go, according to Bell Potter?

A key approval is expected to boost the Bubs share price.

Read more »

a woman in a business suit looks wide eyed and interested as she holds a tin can with string to hear ear listening to some news.
Broker Notes

UBS names its 10 top ASX picks for the next 3-6 months

Here are the 10 ASX shares UBS thinks could outperform.

Read more »

Happy teen friends jumping in front of a wall.
Broker Notes

Guess which ASX stock could rise 85%

Bell Potter sees significant upside from this stock.

Read more »

Buy the dip written on a yellow sign.
Broker Notes

Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today

A leading expert believes Pro Medicus shares are well-place to rebound.

Read more »